2002
DOI: 10.1054/cuog.2001.0243
|View full text |Cite
|
Sign up to set email alerts
|

Prevention and management of ovarian hyperstimulation syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
15
0
1

Year Published

2006
2006
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(16 citation statements)
references
References 8 publications
0
15
0
1
Order By: Relevance
“…The odds ratio for AMH alone was 1.7856, (P= 0.0003) and for E2 was 1.0005, (P= 0.0455). No precise cut-off level for E2 during stimulation has been agreed upon by consensus 5 . Normally, a high or rapidly rising E2 on the day of trigger is a predictor of OHSS 13 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The odds ratio for AMH alone was 1.7856, (P= 0.0003) and for E2 was 1.0005, (P= 0.0455). No precise cut-off level for E2 during stimulation has been agreed upon by consensus 5 . Normally, a high or rapidly rising E2 on the day of trigger is a predictor of OHSS 13 .…”
Section: Discussionmentioning
confidence: 99%
“…polycystic ovarian syndrome (PCOS). It is also more common in cycles where clinical pregnancy occurred, and where human chorionic gonadotropins (hCG) used for ovulation trigger and luteal support 5 .…”
Section: Introductionmentioning
confidence: 99%
“…Whereas critical OHHS is associated with tense ascites, hematocrit >55%, oliguria/anuria, thromboembolism and acute respiratory distress syndrome. 5,6 Several factors have been demonstrated to independently increase the risk of developing OHSS such as age < 30 years, polycystic ovaries, high serum estradiol at HCG trigger or rapidly rising serum estradiol, previous episodes of OHSS, large number of small follicles (8 to 12 mm) seen on ultrasonography during ovarian stimulation, use of HCG as opposed to progesterone, for luteal phase support after IVF, large number of oocytes retrieved (>20), and high anti-mullerian hormone (>3.36 ng/mL). [5][6][7] Management is essentially supportive until the condition resolves spontaneously.…”
Section: -3mentioning
confidence: 99%
“…Mild and moderate OHHS can be managed on an outpatient basis. 6 Analgesia using paracetamol or codeine is appropriate. Non-steroidal antiinflammatory drugs should not be used.…”
Section: -3mentioning
confidence: 99%
“…Individualizing IVF protocol includes modification of the starting dose of FSH, use of antagonist protocol instead of long agonist protocol, lowering the dose of hCG needed to trigger ovulation 18 or using GnRHa for triggering ovulation in GnRH antagonist treated cycles 19 . Secondary preventive measures include coasting 18 , withholding hCG and cycle cancellation 20 , cryopreservation of all embryos 21 , intravenous administration of albumin 22 or hydroxyethyl starch (HES) 23 during or immediately after oocyte retrieval, use of cabergoline 24 or the vasopressin V1a receptor antagonist, relcovaptan 25 .…”
Section: Introductionmentioning
confidence: 99%